Insights on the use of biosimilars in the treatment of inflammatory bowel disease

Biologic therapy, such as those that target tumor necrosis factor (TNF) signaling, has proven to be an efficacious method of treatment for patients with inflammatory bowel disease (IBD) with regards to symptom management and mucosal healing. However, the rising prevalence of IBD worldwide and the ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Michael K, Shih, David Q, Chen, Gary C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360634/
https://www.ncbi.nlm.nih.gov/pubmed/28373759
http://dx.doi.org/10.3748/wjg.v23.i11.1932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360634/
https://www.ncbi.nlm.nih.gov/pubmed/28373759
http://dx.doi.org/10.3748/wjg.v23.i11.1932

Ejemplares similares